Brief: Anika Therapeutics Q3 Revenue USD 38.753 Million

Anika Therapeutics

31/10/2024 11:05

Oct 31 (Reuters) - Anika Therapeutics Q3 net income USD -29.918 million.
* Q3 pretax profit USD -27.611 million
* Q3 income from operations USD -28.017 million
* Q3 gross profit USD 1.44 million